Khalid Abd El Ghany | Microbial biotechnology | Best Researcher Award

Assist Prof Dr. Khalid Abd El Ghany | Microbial biotechnology | Best Researcher Award

Assist Prof Dr. Khalid Abd El Ghany, Egyption Drug Authoriity, Egypt

Dr. Khalid Abd El Ghany is a Post-Approval Control Manager at the Egyptian Drug Authority (since 2021) with over two decades of experience in the pharmaceutical sector. He holds a Ph.D. in Genetic Engineering and Biotechnology from Al-Sadat City University (2018) and has completed post-doctoral research at the Egyptian Drug Authority. He is a skilled researcher with numerous publications and expertise in microbial biotechnology. A recipient of the Egyptian Drug Authority Hero’s Certificate (2022) and the Ideal Pharmacist Award (2016), Dr. Khalid is also active in social initiatives, holding leadership roles in various organizations. πŸ“šπŸŒ

 

Publication profile

Google Scholar

Education Background

Dr. Khalid Abd El Ghany has a distinguished educational background in pharmacy and biotechnology. He earned his B.Sc. in Pharmacy with honors from Al-Azhar University, Egypt, in 1994. Later, he pursued an M.Sc. in Microbial Biotechnology from Al-Sadat City University (2012-2014), further advancing his expertise with a Ph.D. in Genetic Engineering and Biotechnology from the same institution in 2018. Since 2020, he has been a post-doctoral researcher at the Egyptian Drug Authority, where he continues to contribute to the field of microbial biotechnology. πŸ“˜πŸ”¬

 

Professional Experience

Dr. Khalid Abd El Ghany has extensive experience in pharmaceutical regulation and management. Since 2021, he has served as the Post-Approval Control Manager at the Egyptian Drug Authority (EDA). From 2017 to 2021, he was the Deputy Head of the Inspection Department at NODCAR, where he also worked in the Microbiology Lab from 2012 to 2017. His career began as a pharmacist at Arab Drug Company (1995-1996), followed by years in the private pharmaceutical sector, where he was the owner and director from 1996 to 2011. πŸŒŸπŸ”¬

 

Research Focus

Dr. Khalid Abd El Ghany’s research is primarily centered on microbial biotechnology and genetic engineering. His work involves probiotics, especially Lactobacillus acidophilus, in cancer treatment and antioxidant activities. He also focuses on vaccine design, integrating immunoinformatics and cheminformatics to target pathogens like Klebsiella pneumoniae and Pseudomonas aeruginosa. Additionally, Dr. Khalid has contributed to studies on Ξ²-glucan production, antimicrobial agents, and the potential of probiotics against viral infections, including COVID-19. His work is diverse, covering biotechnology, immunology, and pharmaceutical sciences. πŸ§¬πŸ’‰

 

Conclusion

With his strong academic background, significant experience in pharmaceutical regulation, a proven track record in research, and leadership in social initiatives, Assist. Prof. Dr. Khalid Abd El Ghany is a strong candidate for the Best Researcher Award. His dedication to both scientific advancement and community service makes him a well-rounded contender for this recognition.

 

Publication Top Notes

  • A potential role of Lactobacillus acidophilus LA1 and its exopolysaccharides on cancer cells in male albino mice – 43 citations (2015) πŸ“‘πŸ§¬
  • In Silico Designing of a Multitope Vaccine against Rhizopus microsporus – 26 citations (2021) πŸ’‰πŸ–₯️
  • Evaluation of antioxidant and antitumor activities of Lactobacillus acidophilus bacteria – 20 citations (2014) πŸ§ͺ🦠
  • Screening and molecular identification of lactic acid bacteria producing Ξ²-glucan – 13 citations (2022) 🧬🍏
  • Description of isolated LAB producing Ξ²-glucan and evaluation of its therapeutic effect – 11 citations (2016) 🧫🩺
  • Integration of Immunoinformatics and Cheminformatics for Vaccine Design – 5 citations (2023) πŸ§¬πŸ’‰
  • Molecular Characterization and Optimization of Ξ²-Glucan Production from Pediococcus parvulus – 3 citations (2018) πŸ§¬πŸ“Š
  • Lactiplantibacillus plantarum and Saussurea costus as Therapeutic Agents – 2 citations (2023) πŸ§¬πŸ’Š
  • Role of probiotic bacteria against virus pathogenesis: Defence against COVID-19 – 1 citation (2024) 🦠🧬
  • Efficacy of Ξ²-glucan in an acute model of diabetes – 1 citation (2022) πŸ©ΊπŸ“Š
  • Synthesis, Molecular Docking Studies of Pyrazolo[1,5-a]pyrimidines – 2023 πŸ“‘βš—οΈ

 

Rushna Wazahat | Immunology and Microbiology | Best Researcher Award

Rushna Wazahat | Immunology and Microbiology | Best Researcher Award

Mrs Rushna Wazahat, Jamia Hamdard, India

Based on the provided details, Mrs. Rushna Wazahat is a strong candidate for the Best Researcher Award. Her academic background, extensive research experience, and significant contributions to the field of medical microbiology, particularly in tuberculosis diagnosis, make her highly suitable for this award.

Publication profile

google scholar

Education

Mrs. Rushna Wazahat has a robust educational foundation, beginning with a B.Sc. in Botany (Hons.) from Ramjas College, University of Delhi, followed by an M.Sc. in Medical Microbiology from HIMSR, Jamia Hamdard. Her thesis work on the efficacy of diagnostic tools for tuberculosis showcases her early commitment to impactful research. Currently, she is pursuing a Ph.D. at Jamia Hamdard, focusing on novel biomarkers for tuberculosis diagnosis, which underlines her dedication to advancing medical science.

Research & Teaching

With experience as a Junior Research Scientist at Valetude Primus Healthcare and a Tutor/Demonstrator at SGT Medical College, Mrs. Wazahat has gained valuable hands-on experience. Her role as a Research Assistant in a DBT project on innate immunity during Mycobacterium tuberculosis infection further highlights her research acumen. Her ongoing Ph.D. research in the Department of Biochemistry at Jamia Hamdard continues to build on her expertise in tuberculosis research.

Publications

Mrs. Wazahat has published several impactful research papers in reputable journals. Her work spans various aspects of tuberculosis research, including diagnostic methods and epigenetic regulations in Mycobacterium tuberculosis infection. These publications, such as her contributions to the Indian Journal of Tuberculosis and Journal of Microbiological Methods, demonstrate her significant contributions to the field and her ability to communicate complex research effectively.

Seminars & Workshops

Her active participation in international conferences, such as the 2023 International Annual Conference on Medicine and Surgery, and various workshops on scientific writing, ethics, and hospital infection control, reflects her commitment to continuous learning and knowledge dissemination. These engagements not only enhance her own expertise but also contribute to the broader scientific community.

Poster Presentations

Mrs. Wazahat has a strong track record in poster presentations, having won several awards, including the Best Poster Award at the 6th International Leh Symposium 2022. Her success in innovation categories and other competitive events highlights her creativity and ability to present research compellingly.

Extra-Curricular Activities

Her involvement in volunteer work and participation in extracurricular activities, such as calligraphy and leaf mosaic contests, demonstrates her well-rounded personality and commitment to community engagement.

Conclusion

In conclusion, Mrs. Rushna Wazahat’s extensive academic background, impactful research, and active participation in scientific discourse make her an exemplary candidate for the Best Researcher Award. Her work has significant implications for tuberculosis diagnosis and treatment, making her a valuable asset to the scientific community.

Publication top notes

Antimicrobial susceptibility patterns of an emerging multidrug resistant nosocomial pathogen: Acinetobacter baumannii

A strip-based assay for detection of CrfA enzyme activity to differentiate Mycobacterium tuberculosis and non-tuberculous mycobacteria

Epigenetic regulations in Mycobacterium tuberculosis infection

Assessment of Conventional and Molecular Methods in the Routine Management of Tuberculosis in a High Tuberculosis Burden Setting

Strategic Diagnosis-Unraveling Tuberculosis-A comprehensive Approach

96well-formatted CrfA assay for differentiation of Mycobacterium tuberculosis and Non-tuberculous mycobacteria

Structural basis for the role of C-terminus acidic tail of Saccharomyces cerevisiae ubiquitin-conjugating enzyme (Rad6) in E3 ligase (Bre1) mediated recognition of histones

Assessment of Conventional and Molecular Methods in the Routine Management of Tuberculosis in a High Tuberculosis Burden Setting

Assessment of Conventional and Molecular Methods in the Routine Management of Tuberculosis in a High Tuberculosis Burden Setting